Literature DB >> 12126735

Attenuation of hypercholesterolemia and hyperglycemia in ob/ob mice by NPY Y2 receptor ablation.

Philippe Naveilhan1, Lennart Svensson, Susanne Nyström, A Jonas Ekstrand, Patrik Ernfors.   

Abstract

Neuropeptide Y (NPY) is a 36 amino acid peptide well known for its role in regulating food intake and energy homeostasis. It has previously been shown that the NPY Y2 receptor is required for a full biological response to leptin in the central nervous system. We have examined the impact of this receptor on plasma levels of lipid and cholesterol in wild type and obese (ob/ob) mice. The results show that an absence of Y2 in female mice has no effect on cholesterol level in normal lean mice but profoundly decreases serum cholesterol and glucose levels in ob/ob mice. We conclude that NPY, interacting with the Y2 receptor, participates in cholesterol and glucose homeostasis of obese mice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12126735     DOI: 10.1016/s0196-9781(02)00042-6

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  6 in total

1.  NPY receptors as potential targets for anti-obesity drug development.

Authors:  Ernie Yulyaningsih; Lei Zhang; Herbert Herzog; Amanda Sainsbury
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

2.  NPY neuron-specific Y2 receptors regulate adipose tissue and trabecular bone but not cortical bone homeostasis in mice.

Authors:  Yan-Chuan Shi; Shu Lin; Iris P L Wong; Paul A Baldock; Aygul Aljanova; Ronaldo F Enriquez; Lesley Castillo; Natalie F Mitchell; Ji-Ming Ye; Lei Zhang; Laurence Macia; Ernie Yulyaningsih; Amy D Nguyen; Sabrina J Riepler; Herbert Herzog; Amanda Sainsbury
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

Review 3.  Updating experimental models of diabetic cardiomyopathy.

Authors:  J Fuentes-Antrás; B Picatoste; A Gómez-Hernández; J Egido; J Tuñón; Ó Lorenzo
Journal:  J Diabetes Res       Date:  2015-04-20       Impact factor: 4.011

4.  FTO is a relevant factor for the development of the metabolic syndrome in mice.

Authors:  Kathrin Ikels; Stefanie Kuschel; Julia Fischer; Wolfgang Kaisers; Daniel Eberhard; Ulrich Rüther
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

5.  Peripherally Administered Y2-Receptor Antagonist BIIE0246 Prevents Diet-Induced Obesity in Mice With Excess Neuropeptide Y, but Enhances Obesity in Control Mice.

Authors:  Liisa Ailanen; Laura H Vähätalo; Henriikka Salomäki-Myftari; Satu Mäkelä; Wendy Orpana; Suvi T Ruohonen; Eriika Savontaus
Journal:  Front Pharmacol       Date:  2018-04-05       Impact factor: 5.810

Review 6.  Metabolic and Biochemical Stressors in Diabetic Cardiomyopathy.

Authors:  Vasundhara Kain; Ganesh V Halade
Journal:  Front Cardiovasc Med       Date:  2017-05-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.